Related Articles
Responses to crizotinib in a patient with c-ros oncogene 1, receptor tyrosine kinase‑positive advanced lung adenocarcinoma: A case report
Overexpression of the ros1 gene in primary human gliomas may contribute to malignant progression
Clinical activity of crizotinib in lung adenocarcinoma harboring a <em>HLA_A</em>‑<em>ROS1</em> rearrangement: A case report
Identification of bile biomarkers of biliary tract cancer through a liquid chromatography/mass spectrometry-based metabolomic method
ALK inhibitors and advanced non-small cell lung cancer (Review)